These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 321478)

  • 21. [Resistance patterns of certain Enterobacteriaceae in hospital and outpatients, with particular reference to trimethoprim-sulfamethoxazole (author's transl)].
    Freitag V
    MMW Munch Med Wochenschr; 1976 Feb; 118(9):275-8. PubMed ID: 817195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibiotic sensitivity of gram-negative bacilli isolated from lesions since 1965].
    Yamaji Y; Takahashi M; Miyanaga Y; Todome Y; Motoyama M
    Jpn J Antibiot; 1968 Feb; 21(1):25-33. PubMed ID: 4174373
    [No Abstract]   [Full Text] [Related]  

  • 23. Fosfomycin and plasmidic resistance.
    Baquero F; López-Brea M; Valls A; Cañedo T
    Chemotherapy; 1977; 23 Suppl 1():133-40. PubMed ID: 318973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin.
    McHugh GL; Moellering RC; Hopkins CC; Swartz MN
    Lancet; 1975 Feb; 1(7901):235-40. PubMed ID: 46385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic absorption of sulphadiazine, silver sulphadiazine and sodium sulphadiazine through human burn wounds.
    Aoyama H; Yokoo K; Fujii K
    Burns; 1990 Jun; 16(3):163-5. PubMed ID: 2383353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM; Gebicka K; Borowski J
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
    [No Abstract]   [Full Text] [Related]  

  • 27. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing.
    Fraser JF; Bodman J; Sturgess R; Faoagali J; Kimble RM
    Burns; 2004 Feb; 30(1):35-41. PubMed ID: 14693084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [General effects of antibiotic associations on certain Enterobacteriaceae (Escherichia, Salmonella, Klebsiella)].
    Cluzel R; Michel J; Cluzel M; Sirot J
    Pathol Biol (Paris); 1971; 19(11):627-36. PubMed ID: 4933627
    [No Abstract]   [Full Text] [Related]  

  • 29. Transferable drug resistance (R-factor) among the enterobacteriaceae in urinary tract infections: a study at an urban hospital in Bangladesh.
    Chowdhury MA; Rahman KM; Miah MR; Haq JA
    J Trop Med Hyg; 1994 Jun; 97(3):161-6. PubMed ID: 8007056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of sepsis in superficial burns: effect of 1% Silver Sulphadiazine.
    Sharma BC; Wosornu L; Paonaskar V
    Med J Zambia; 1979; 13(2):35-40. PubMed ID: 263370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum and tissue silver levels after burns treated with silver compounds].
    Kartal A; Tatkan Y; Belviranli M; Sahin M; Duman S; Karahan O; Gurbilek M; Temur S
    J Chir (Paris); 1989 Dec; 126(12):676-81. PubMed ID: 2621235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta-lactam and aminoglycoside resistant phenotypes in enterobacteria isolated in pediatrics].
    Ben Hassen A; Chourou O; Fendri C; Kammoun A; Ben Redjeb S
    Bull Soc Pathol Exot; 1991; 84(2):145-53. PubMed ID: 1914045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical silver sulphadiazine: side effects and urinary excretion.
    Lockhart SP; Rushworth A; Azmy AA; Raine PA
    Burns Incl Therm Inj; 1983 Sep; 10(1):9-12. PubMed ID: 6640389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of in vitro sensitivity to sulfadiazine silver.
    McManus AT; Denton CL; Mason AD
    Arch Surg; 1983 Feb; 118(2):161-6. PubMed ID: 6401421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Level and evolution of the resistance of gram-negative bacilli].
    Duval J; Atlan G; Gaudin H; Kerzoncuf A; Mathieu-Saint-Laurent P; Mora M
    Pathol Biol (Paris); 1969 Oct; 17(19):825-31. PubMed ID: 4907918
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined use of topical cyclosporin A and silver sulphadiazine on allografts infected with Pseudomonas in burned rats.
    Lai CS; Miskell P; Gonce SJ; Alexander JW; Babcock GF
    Burns Incl Therm Inj; 1987 Jun; 13(3):181-4. PubMed ID: 3111646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gram-negative bacteria resistant to antibiotics in foods].
    Dias JC; Hofer E
    Mem Inst Oswaldo Cruz; 1985; 80(4):411-21. PubMed ID: 3837834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim.
    Ekström B; Forsgren U; Ortengren B; Bergan T
    Infection; 1979; 7 Suppl 4():S359-66. PubMed ID: 389812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Our experience with the use of cerium sulphadiazine in the treatment of extensive burns.
    Koller J; Orsag M
    Acta Chir Plast; 1998; 40(3):73-5. PubMed ID: 9782621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.